Dermatologi DK

Carsten Sauer Mikkelsen, specialist in dermato-venereologi at Aalborg Universitets Hospital & Aleksandra Lesiak, specialist in dermatology-venereology at the Department of Dermatology, at the Medical University of Lodz, Studies in English, Poland presents: The 4th Scientific Conference of the African Society of Dermatology and Venereology (ASDV) brought together dermatologists from across Africa and beyond to address critical issues in skin care, particularly in African contexts. Topics ranged from dermatological challenges and innovations in skin-of-color dermatology to the unique hair characteristics in African populations and the complexities of treating conditions like Xeroderma Pigmentosa. #ASDV24 #Skindisease

John S. Barbieri presents: Acne is more than just a skin condition; it can lead to significant social stigma. This study explores the extent of stigmatizing attitudes toward individuals with acne, revealing the challenges they might face in relationships, school, and the workplace. #Acne #Skin #Stigma

Pletskaldethed kan også ramme øjenvipper og øjenlåg Alopecia areata, pletskaldethed, kan ud over at ramme håret også føre til tab af skæg, øjenbryn og øjenvipper. Tilfælde hvor det alene er øjenlåg og øjenvipper, der rammes, er i risiko for at blive misdiagnosticeret samtidig med. Det er ligeledes en sygdom, der er dårligt forstået og som har stor psykisk påvirkning af den enkelte patient. Det kan du læse mere om i magasinet Immunology perspectives, udgivet af BestPractice Nordic DK, hvor der er en række interessante artikler. 👉Opret en gratis profil og læse magasinet: https://lnkd.in/de4hEacS

Professor Matthias Augustin outlines in this MEDtalk the WHO-5 questionnaire as an effective instrument for measuring patient well-being and suggests its integration into routine care to better identify and address the psychosocial burdens in psoriasis patients. #Dermatology #Treatments #Psoriasis

Professor Matthias Augustin presents a study on tildrakizumab, which aimed to improve the well-being of psoriasis patients. The study was unique in measuring well-being as the primary endpoint, using the WHO-5 questionnaire alongside other quality-of-life metrics. One of the results showed that tildrakizumab significantly improves patients’ well-being in patients with moderate-to-severe plaque psoriasis. #PlaquePsoriasis

This case report presents the simultaneous occurrence of linea nigra and vitiligo in a 3-year-old child. The simultaneous occurrence of linea nigra and vitiligo has not been described in the literature before. Read the article below written by Carsten Sauer Mikkelsen, specialist in dermato-venereology at Aalborg University Hospital, Casper Bo Poulsen, MD at Research Unit Dermatology department of Aalborg University Hospital, Luit Penninga, specialist in surgery at Rigshospitalet and Peter Bjerring, MD and Professor in Dermato-venereology at Aalborg University Hospital.

In March 2024, San Diego hosted the 82nd annual AAD meeting. Dermatologist Carsten Sauer Mikkelsen attended the world’s largest annual dermatology congress and reports some of his personal highlights, focusing on mental health and skin of color. #ADD24 #Dermatology #MentalHealth

I denne MEDtalk redegør Lars Erik Kristensen, professor, forskningschef, Parker instituttet, for de enkelte JAK-hæmmeres virkning, selektivitet og safety generelt for immunmedierende lægemidler, herunder hvorfor de især er gode til patienter, der samtidig har sygdom relateret til flere specialer. #Reumatoidartritis #Psoriasisartritis #Plakpsoriasis #IBD #JAKhæmmere

In this MEDtalk, Dr. Andy Blauvelt presents the best medications for psoriasis emerging, according to the Cochrane Group. The focus of the Cochrane review is the one-year efficacy in treating patients with moderate to severe plaque psoriasis without psoriatic arthritis. #Psoriasis #Medications #Arthritis

Dr. Robert Ofenloch presents: This study assessed the allergic reactivity to eugenol in 18 concentrations using patch tests and repeated open application tests (ROAT). #Allergy #ROAT #Eugenol